Single nucleotide polymorphisms and the future of genetic epidemiology

Clinical Genetics

Volumn 58, Issue 4, 2000, Pages 250-264

  Schork, Nicholas J ^a,b,c,e,f,g   Fallin, Daniele ^a   Lanchbury, Jerry S ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c JACKSON LABORATORY   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GENSET Corporation of La Jolla   (United States)

^f GENSET   (France)

^g Genset Corporation   (United States)

Author keywords

Genetic epidemiology; Polymorphism; SNPs

Indexed keywords

NUCLEOTIDE; XENOBIOTIC AGENT;

DIET; DISEASE PREDISPOSITION; ENVIRONMENT; GENE MAPPING; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC RISK; GENOME; HUMAN; MEIOSIS; MICROORGANISM; MOUSE; NONHUMAN; PHENOTYPE; PLANT; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; STIMULATION;

ALLELES; CHROMOSOME MAPPING; EPIDEMIOLOGY; FEMALE; GENETIC TECHNIQUES; HAPLOTYPES; HUMANS; INTERNET; MALE; PEDIGREE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 0033810469     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.580402.x     Document Type: Review

References (123)

1. Snipping away at genome patenting
2. A second private genome project
3. As consortium plnas free SNP map of human genome
4. Analysts, firms pour cold water on SNP Consortium
5. Variations on a theme: Cataloguing human DNA sequence variation
6. Playing chicken' over gene markers
7. New goals for the US Human Genome Projects: 1998-2003
8. Japan bids to catch up on gene sequencing
9. DNA chips: An array of possibilities
10. DNA chips: State of the art
11. Construction of a genetic linkage map in man using restriction fragment length polymorphisms
12. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
13. Characterization of single-nucleotide polymorphisms in coding regions of human genes
14. The essence of SNPs
15. Ethnic affiliation estimation by use of population-specific DNA markers
16. Survey of human and rat microsatellites
17. Mutation of human short tandem repeats
18. The origin of interspersed repeats in the human genome
19. Genetic dissection of complex traits
20. Who's afraid of epistasis?
21. Genetically complex cardiovascular traits: Origins, problems, and potential solutions
22. Genetics of complex disease
23. Polygenic disease: Methods for mapping complex disease traits
24. The future of genetic studies of complex human diseases
25. A manic depressive history
26. The future of genetic epidemiology
27. A nonmathematical overview of modern gene mapping techniques applied to human diseases
28. A gene map of the human genome
29. Genomics: Journey to the center of biology
30. Mapping complex genetic traits in humans: New methods using a complete RFLP linkage map
31. Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms
32. A genetic linkage map of the human genome
33. Centre d'Etude du Polymorphisme Humain (CEPH): Collaborative genetic mapping of the human genome
34. Comprehensive human genetic maps: Individual and sex-specific variation in recombination
35. An extreme-sibpair genome scan for genes regulating blood pressure
36. The use of a genetic map of biallelic markers in linkage studies
37. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
38. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
39. Identification of clusters of biallelic polymorphic sequence-tagged sites (pSTSs) that generate highly information and automatable markers for genetic linkage mapping
40. Mapping genes that underlie ethnic differences in disease risk: Methods for detecting linkage in admixed populations, by conditioning on parental admixture
41. Evolution and distribution of (GT)n repetitive sequences in mammalian genomes
42. Haplotype structure and population-genetics inferences from nucleotide-sequence variation in human lipoprotein lipase
43. It's raining SNPs, hallelujah?
44. Linkage disequilibrium as a gene-mapping tool
45. High-resolution genetic mapping of complex traits
46. Sibpairs versus pedigrees: What are the advantages?
47. Linkage analysis, kinship, and the short-term evolution of chromosomes
48. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins
49. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region
50. Linkage disequilibrium patterns vary with chromosomal location: A case study from the von Willebrand Factor Region
51. Linkage disequilibrium in growing and stable populations
52. Allelic disequilibrium and allele frequency distribution as a function of social and demographic history
53. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
54. The accuracy of haplotype frequency estimation involving biallelic markers and genotypic data
55. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci
56. Detecting disease-predisposing variants: The haplotype method
57. Combined analysis of genetic segregation and linkage under an oligogenic model
58. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods
59. Testing the association between polymorphic markers and quantitative traits in pedigrees
60. Assessing genetic linkage and association with robust components of variance approaches
61. Pharmacogenetics
62. Pharmacogenetics and drug metabolism
63. Xenobiotics, dietary interventions, and genetically-mediated therapies
64. Nicotine metabolism defect reduces smoking
65. Functional foods
66. An apportionment of human DNA diversity
67. Human races: A genetic and evolutionary perspective
68. The future of genetic case/control studies
69. Clearing the air over association studies or wither association?
70. The new genomics: Global views of biology
71. The future is function
72. Integrated phenotyping, disease models, and pathophysiologic databases
73. Research instrumentation for the 21st century: Progress toward complete genomic maps and sequence data bases, and indexes of protein gene products
74. Genotyping of PCR-based polymorphisms and linkage disequilibrium analysis at the NFI locus
75. Haplotypes of angiotensinogen in essential hypertension
76. Haplotype analysis of hemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes
77. An analysis of linkage disequilibrium in the Interleukin-1 gene cluster, using a novel grouping method for multiallelic markers
78. DNA sequence diversity in a 9.7-kb region of the human lipo-protein lipase gene
79. A scan for linkage disequilibrium across the human genome
80. Linkage disequilibrium and allele frequency distributions for 114 single nucleotide polymorphisms in five populations
81. Genetic epidemiology of single-nucleotide polymorphisms
82. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
83. Genealogy of the CCR5 locus and chromokine system gene variants associated with altered rates of HIV-1 disease progression
84. Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families
85. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival
86. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
87. Different frequencies of angiotensinogen-converting enzyme genotypes in older hypertensive individuals
88. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
89. Molecular basis of human hypertension: Role of angiotensinogen
90. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate
91. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking
92. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking
93. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease
94. The response to lovastatin treatment in patients with heterozygous familial hypercholesteremia is modulated by apolipoprotein E polymorphism
95. High frequencies of alpha thalassemia are the result of natural selection by malaria
96. Human gene for physical performance
97. The ACE gene and muscle performance
98. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
99. Expression of the H2-Ea gene is modulated by a polymorphic transcriptional enhancer
100. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies
101. Functional reassessment of P16 variants using a transfection-based assay
102. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
103. Differences in IL-10 production are associated with joint damage
104. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes
105. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and as association with systemic-onset juvenile chronic arthritis
106. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene
107. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
108. The Gly972-Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells
109. Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression
110. Expression and characterization of a dopamine D4R variant associated with delusional disorder
111. The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation
112. Polymorphism of the human alcohol dehydrogenase 4 (ADH4) promoter affects gene expression
113. Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants
114. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT 1B receptor
115. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha